Evidence map›Paper›PMID 37947735›Full record

ArticleNanomaterials (Basel, Switzerland)2023

Nanofibers and Nanotextured Materials: Design Insights, Bactericidal Mechanisms and Environmental Advances.

Touseef Amna, M Shamshi Hassan

Abstract readEditorial
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Touseef AmnaDepartment of Biology, College of Science, Al-Baha University, Albaha 65799, Saudi Arabia.ORCID 0000-0003-4886-1363
M Shamshi HassanDepartment of Chemistry, College of Science, Al-Baha University, Albaha 65799, Saudi Arabia.ORCID 0000-0003-3261-0957

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antibiotic resistance is rising and poses a serious threat to human health on a worldwide scale. It can make it more difficult to cure common infections, raise medical expenditures, and increase mortality. In order to combat the development of biofilms and treat fatal bacterial infections, multifunctional polymeric nanofibers or nanotextured materials with specific structural features and special physiochemical capabilities have become a crucial tool. Due to the increased antibiotic resistance of many diseases, nanofibers with antibacterial activity are essential. Electrospinning is a flexible process able to produce fine fibers with specified properties by modifying variables such as the concentration of the solution, the feed flow, and the electric voltage. Substantial advancements have been made regarding the formation of nanofibers or nanotextured materials for a variety of applications, along with the development of electrospinning techniques in recent years. Using well-defined antimicrobial nanoparticles, encapsulating traditional therapeutic agents, plant-based bioactive agents, and pure compounds in polymer nanofibers has resulted in outstanding antimicrobial activity and has aided in curing deadly microbial infections. A plethora of studies have revealed that electrospinning is an effective technique for the production of antimicrobial fibers for the environmental, biomedical, pharmaceutical, and food sectors. Nevertheless, numerous studies have also demonstrated that the surface characteristics of substrates, such as holes, fibers, and ridges at the nanoscale, have an impact on cell proliferation, adhesion, and orientation.

Indexed as

antimicrobialbactericidal mechanismselectrospinningenvironmental remediationnanofibers

Identifiers

PMID37947735
PMCPMC10647218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.